Abstract

<p>There has been much debate about assisted suicide as a therapeutic option.  At the same time the Government strategy has been to invest in palliative care developments with a view to improving end of life care. </p><p>The presentation will address:</p><ul> <li>How a change in the law might impact on clinical care</li> <li>The main arguments deployed in the recent Parliamentary debate</li> <li>How treatment cessation decision differ from euthanasia</li> <li>The nature of double effect as a concept in oncology.</li> </ul><br>